Tag

Manufacturing

Browsing

Year in Review: FDA Hot Issues 2017

By: Ronie Schmelz
Counsel at Tucker Ellis LLP

Despite Deregulation in 2017, Cosmetic Companies Remain FDA Focus

President Donald Trump has made deregulation a cornerstone of his administration, demanding that for every new regulation proposed, regulatory agencies identify two regulations for elimination; however, this directive has not impeded regulatory oversight at the U.S. Food and Drug Administration (FDA).  Although the number of FDA Warning Letters sent to cosmetic, skin care, and other personal care companies has decreased significantly under the new administration, these companies still remain a focus for FDA.  While the future is impossible to predict, the following summary of regulatory activity in 2017 provides a good guidepost for the types of claims to avoid so that your company does not become the recipient of an FDA Warning Letter.

Expanding Exports of U.S. Personal Care and Beauty Products

Jamie Merriman is Acting Director of ITA’s Office of Strategic Partnerships

With more than $12 billion in exports in 2016, U.S. branded personal care and cosmetics are among the most highly desired brands in many overseas markets.  During the past five years, U.S. exports in the sector have grown at five percent to six percent annually.  Employing thousands of Americans across the country, the U.S. personal care and beauty industry is a critical component of the U.S. economy.